Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Deadline: Jul 19, 2022 (Full proposal)

Grant amount: Up to US $3,000,000

Fields of work: Human Genome & Genetics Genetics & Genomics

Applicant type: For-Profit Business, Government Entity, Indigenous Group, Nonprofit

Funding uses: Research

Location of project: Marshall Islands; Micronesia, Federated States Of; United States; American Samoa; Guam Show all

Location of residency: Marshall Islands; Micronesia, Federated States Of; United States; American Samoa; Guam Show all

Overview:

The purpose of this FOA is to provide support for applications that propose a novel genome editing clinical trial that includes at least two different diseases, using the same genome editor, route of administration, and delivery system.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed June 29, 2022 and last updated April 18, 2022